Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Non Operating Income (2016 - 2025)

Sanara MedTech's Non Operating Income history spans 10 years, with the latest figure at -$2.2 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 62.76% year-over-year to -$2.2 million; the TTM value through Dec 2025 reached -$7.7 million, down 140.86%, while the annual FY2025 figure was -$7.7 million, 140.82% down from the prior year.
  • Non Operating Income reached -$2.2 million in Q4 2025 per SMTI's latest filing, down from -$2.1 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$6.0 in Q1 2023 to a low of -$2.2 million in Q4 2025.
  • Average Non Operating Income over 5 years is -$701620.6, with a median of -$267336.0 recorded in 2024.
  • Peak YoY movement for Non Operating Income: skyrocketed 100.0% in 2023, then tumbled 4455500.0% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$144180.0 in 2021, then plummeted by 621.54% to -$1.0 million in 2022, then soared by 96.5% to -$36449.0 in 2023, then tumbled by 3537.18% to -$1.3 million in 2024, then plummeted by 62.76% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Non Operating Income are -$2.2 million (Q4 2025), -$2.1 million (Q3 2025), and -$2.0 million (Q2 2025).